Mikiko Takahashi Selected Research

Mikiko Takahashi Research Topics

Disease

8	Neoplasms (Cancer) 02/2023 - 06/2005
5	Neoplasm Metastasis (Metastasis) 01/2024 - 06/2005
2	Carcinoma (Carcinomatosis) 12/2023 - 09/2013
2	Fever (Fevers) 10/2019 - 01/2017
2	Acute Kidney Injury (Acute Renal Failure) 10/2019 - 02/2011
2	Fibrosis (Cirrhosis) 10/2019 - 10/2011
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2010 - 11/2009
1	Kidney Diseases (Kidney Disease) 04/2024
1	Hemangiosarcoma (Angiosarcoma) 01/2024
1	Dementia (Dementias) 12/2023
1	Hematoma 12/2023
1	Hemorrhage 12/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023
1	Sigmoid Neoplasms 12/2022
1	Bile Duct Neoplasms (Bile Duct Cancer) 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Liver Failure 12/2021
1	Edema (Dropsy) 10/2019
1	Oliguria 10/2019
1	Multi-centric Castleman's Disease 10/2019
1	Thrombocytopenia (Thrombopenia) 10/2019
1	Dwarfism 01/2019
1	Microcephaly 01/2019
1	Endometrial Neoplasms (Endometrial Cancer) 05/2018
1	Communicable Diseases (Infectious Diseases) 12/2017
1	Cholangiocarcinoma 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016
1	Bronchiectasis 01/2016
1	Acute Lung Injury 10/2013
1	Necrosis 09/2013
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 09/2013
1	Histiocytic Sarcoma 01/2013
1	Hyperbilirubinemia 01/2013
1	Pathologic Complete Response 01/2013
1	Inflammation (Inflammations) 01/2013
1	Liver Diseases (Liver Disease) 01/2013
1	HIV Infections (HIV Infection) 01/2013
1	Ischemia 02/2011
1	Wounds and Injuries (Trauma) 02/2011
1	Polymyositis 01/2010
1	Disease Progression 01/2010

Drug/Important Bio-Agent (IBA)

2	Bevacizumab (Avastin)FDA Link 12/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 09/2013 - 08/2009
1	Uridine Diphosphate (UDP)IBA 04/2024
1	hexadecanal dehydrogenase (acylating) (fatty acyl-CoA reductase)IBA 04/2024
1	EnzymesIBA 04/2024
1	GalactosyltransferasesIBA 04/2024
1	GlycolipidsIBA 04/2024
1	alkylglycerone-phosphate synthaseIBA 04/2024
1	1-methyl-1-piperidinomethane sulfonateIBA 02/2023
1	atezolizumabIBA 02/2023
1	NivolumabIBA 02/2023
1	IpilimumabIBA 02/2023
1	Immune Checkpoint InhibitorsIBA 02/2023
1	Biomarkers (Surrogate Marker)IBA 02/2023
1	Panitumumab (Vectibix)FDA Link 12/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019
1	Reticulin (Reticular Fiber)IBA 10/2019
1	GlucocorticoidsIBA 10/2019
1	SteroidsIBA 10/2019
1	pericentrinIBA 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Indicators and Reagents (Reagents)IBA 12/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017
1	Parathyroid Hormone-Related ProteinIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	SilverIBA 07/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016
1	SurvivinIBA 10/2013
1	Androgen Receptors (Androgen Receptor)IBA 09/2013
1	MucinsIBA 09/2013
1	10-methyl spiro(4.5)dec-6-en-6-carboxylic acidIBA 09/2013
1	Bile Pigments (Bilin)IBA 01/2013
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2013
1	Collagen Type III (Type III Collagen)IBA 10/2011
1	EndopeptidasesIBA 02/2011
1	Matrix Metalloproteinases (MMPs)IBA 02/2011
1	AutoantibodiesIBA 01/2010
1	AntibodiesIBA 01/2010
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2010

Therapy/Procedure

4	Therapeutics 02/2023 - 01/2010
3	Drug Therapy (Chemotherapy) 12/2021 - 11/2009
2	Radiotherapy 01/2024 - 01/2018
2	Liver Transplantation 01/2013 - 01/2013
1	Neoadjuvant Therapy 12/2023
1	Craniotomy 12/2023
1	Nephroureterectomy 02/2023
1	Nephrectomy 02/2023
1	Laparotomy 12/2022
1	Surgical Instruments (Clip) 01/2022
1	Chemoradiotherapy 02/2021
1	Hysterectomy 05/2018
1	Electrodes (Electrode) 05/2018
1	Traction 01/2016
1	Transplantation 01/2016